PAR 7.32% 22.0¢ paradigm biopharmaceuticals limited..

PAR -v- CUV, page-15

  1. 4,425 Posts.
    lightbulb Created with Sketch. 6967
    Yes I quite enjoy researching more into PAR as we wait during this share price consolidation phase...
    Ok here is what I found, nothing too scientific in terms of research, just pulled the rough figures off the internet
    and wacked them into Excel to present to you:



    https://hotcopper.com.au/data/attachments/1603/1603456-829d788f2bb6272aa2f765d00d715227.jpg
    Figures in Millions

    https://hotcopper.com.au/data/attachments/1603/1603458-439c62e9250a57022895c171f0aa5596.jpg

    Mr Snapple, yes interesting question and subsequent answer, turns out the UK have more sufferers in terms of % of Population, followed by Australia and then US with US obviously having a greater absolute number. All markets are expecting cases of OA to increase (Think the CAGR is something like 8%)

    Dont think we have any issues with potential market size, I hear the world figure is something crazy like 630 million sufferers!
    Of course no one is suggesting PAR will attract even half of these numbers...a small % like 2% would be still in the hundreds of thousands, even if you really just take the Western World and concentrate only on BMEL related OA.

    Remember, DYOR, these are my opinions.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.015(7.32%)
Mkt cap ! $76.98M
Open High Low Value Volume
21.0¢ 22.5¢ 21.0¢ $242.2K 1.102M

Buyers (Bids)

No. Vol. Price($)
1 16020 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 310000 2
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.